These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 12858072)
21. Editorial: Neuro-Immune Connections to Enable Repair in CNS Disorders. Vanmierlo T; van Horssen J; Hellings N; Broux B Front Immunol; 2020; 11():1425. PubMed ID: 32793198 [No Abstract] [Full Text] [Related]
22. Widening the spectrum of inflammatory disorders of the central nervous system. Graus F Curr Opin Neurol; 2017 Jun; 30(3):292-294. PubMed ID: 28402991 [No Abstract] [Full Text] [Related]
23. Transition from enhanced T cell infiltration to inflammation in the myelin-degenerative central nervous system. Grundtner R; Dornmair K; Dahm R; Flügel A; Kawakami N; Zeitelhofer M; Schoderboeck L; Nosov M; Selzer E; Willheim M; Kiebler M; Wekerle H; Lassmann H; Bradl M Neurobiol Dis; 2007 Dec; 28(3):261-75. PubMed ID: 17889548 [TBL] [Abstract][Full Text] [Related]
24. Recognizing behavioural and psychiatric manifestations of neuroimmunological disorders. Hart HM Dev Med Child Neurol; 2009 Dec; 51(12):927. PubMed ID: 19909305 [No Abstract] [Full Text] [Related]
25. [Autoimmune mechanisms in paraneoplastic neurological diseases: the paradigm of opsoclonus myoclonus ataxia syndrome]. Ovadia H; Karussis D; Abramsky O Harefuah; 2006 Apr; 145(4):298-303, 317. PubMed ID: 16642634 [TBL] [Abstract][Full Text] [Related]
26. Roles of glia-derived cytokines on neuronal degeneration and regeneration. Suzumura A; Takeuchi H; Zhang G; Kuno R; Mizuno T Ann N Y Acad Sci; 2006 Nov; 1088():219-29. PubMed ID: 17192568 [TBL] [Abstract][Full Text] [Related]
27. Neuroinflammation: no rose by any other name. Graeber MB Brain Pathol; 2014 Nov; 24(6):620-2. PubMed ID: 25345892 [No Abstract] [Full Text] [Related]
28. New autoantibody mediated disorders of the central nervous system. Lang B; Dale RC; Vincent A Curr Opin Neurol; 2003 Jun; 16(3):351-7. PubMed ID: 12858073 [TBL] [Abstract][Full Text] [Related]
29. Anti-SOX1 antibodies in patients with paraneoplastic and non-paraneoplastic neuropathy. Tschernatsch M; Singh P; Gross O; Gerriets T; Kneifel N; Probst C; Malas S; Kaps M; Blaes F J Neuroimmunol; 2010 Sep; 226(1-2):177-80. PubMed ID: 20701982 [TBL] [Abstract][Full Text] [Related]
30. The endocannabinoid system in targeting inflammatory neurodegenerative diseases. Centonze D; Finazzi-Agrò A; Bernardi G; Maccarrone M Trends Pharmacol Sci; 2007 Apr; 28(4):180-7. PubMed ID: 17350694 [TBL] [Abstract][Full Text] [Related]
31. [A study on pathomechanisms of paraneoplastic neurological syndrome]. Tanaka K Rinsho Shinkeigaku; 2001 Dec; 41(12):1150-2. PubMed ID: 12235823 [TBL] [Abstract][Full Text] [Related]
39. Model of acute injury to study neuroprotection. Schwartz M; Kipnis J Methods Mol Biol; 2007; 399():41-53. PubMed ID: 18309924 [TBL] [Abstract][Full Text] [Related]